Understanding the key regulators which impact the innate immune response during initial phases of tissue injury, can advance the use of therapeutic approaches which aim at attenuating inflammation and organ damage. Recognition of microbial components by TLRs, initiates the transcription of innate immune signal pathways, that induce the expression of key inflammatory mediators: cytokines, chemokines and adhesion molecules. Beside regulating apoptotic cell death, recent studies have revealed distinct roles for caspases in the optimal production of inflammatory cytokines and host defense against injurious infections. Whether caspases can play an immune regulatory role in vivo has not been sufficiently investigated. This study aims to explore whether the pan caspase inhibitor z-VAD-fmk can control inflammation and cytokine production subsequent to challenging the innate immunity of the exocrine secretory tissues in vivo. Submandibular glands (SMGs) of the C57BL/6 mice were challenged with the TLR3 stimulant: polyinosinic-polycytidylic acid (poly (I:C)). Results obtained from the current study provide evidence that caspases can control immune responses downstream of TLR3 ligation. The present work proposes a novel mechanism that can prevent overactivation of the innate immunity, which typically leads to fatal immune disorders.
Introduction
Apoptosis has been considered as one of the main factors that may be related to loss of SG secretory function (Hayashi, 2011) . In fact, death of acinar and ductal cells is considered to be a major mechanism leading to salivary gland dysfunction in patients with Sjögren's syndrome (Horai et al., 2016) and following irradiation of salivary glands (Acauan et al., 2015) . While apoptosis was classically described as an immunologically silent mode of cell death, several studies have shown that cells and tissues stimulated to undergo apoptosis produce moderate amounts of chemoattractant proteins and cytokines (Cullen et al., 2013) , suggesting that apoptosis and inflammation are inseparably linked. Moreover, recent studies indicate that caspases, the initiators of the apoptotic cell death pathway, are situated at the nexus of vital networks that balance inflammation, antiviral immunity and cell death (Chen et al., 2017) .
Caspases are a family of proteases that have been subdivided functionally into those involved in either apoptosis (caspases-2, −3, −6, −7, −8, −9 and −10 in mammals) or inflammation (caspases-1, −4, −5 and −12 in humans and caspases-1, −11 and −12 in mice) (Cohen, 1997) . While the apoptotic caspases function in the initiation and execution of programmed cell death, inflammatory caspases mediate innate immune responses by cleaving proinflammatory cytokine precursors (for example, pro-IL-1β and pro-IL-18) to initiate inflammation (Man and Kanneganti, 2016) .
Emerging studies have shown that caspase inhibition prevents inflammation via preventing T cell activation, Th2 cytokine production and inflammatory cell infiltration (Iwata et al., 2003) . More recent studies showed that pre-treatment with the cell permeable pan-caspase inhibitor z-Val-Ala-Asp (Ome) fluoro-methyl-ketone (z-VAD-fmk) (which irreversibly binds to the catalytic site of caspase proteases (Gregoli and Bondurant, 1999) ), significantly inhibited the activation of myeloperoxidase (MPO), TNF-α, IL-1β and decreased lung injury in a rat model of severe acute pancreatitis (Liu et al., 2016) . The role played by all mammalian caspases in the control of inflammatory and immune reactions has been comprehensively reviewed (Galluzzi et al., 2016) .
Toll-like receptors (TLRs) are transmembrane pattern recognition receptors, which play key roles in sensing microbial pathogen associated molecular patterns (PAMPs) and mounting an immune response. Indeed, TLRs induce the expression of inflammatory pro-survival factors and cytokines (Janeway and Medzhitov, 2002) , that recruit polymorphonuclear leukocytes (PMNs) to the infection site (Kumar et al., 2006) . TLR3 has been identified as a key sensor for viral dsRNA or its synthetic double stranded (ds)RNA analogue poly (I:C) (Blasius and Beutler, 2010) . In turn, poly (I:C) can elicit apoptosis directly in a TLR3 dependent manner (Salaun et al., 2006) . Despite the recent studies and reviews that propose caspases as the central regulators of apoptosis, inflammation and key effectors of immune responses against microbial infections (Chen et al., 2017; Man and Kanneganti, 2016; McIntire et al., 2009; Philip et al., 2016; Uchiyama and Tsutsui, 2015; Sagulenko et al., 2016) , it is unclear if caspases play an immune regulatory role during acute injury phases in vivo. In the current study, we stimulated the TLR3-mediated innate immune response of the C57BL/6 SMGs via the synthetic dsRNA poly (I:C). The induction of a caspase-dependent apoptotic signal in the glandular cells was substantiated as early as nine hours post poly (I:C) intraductal infusion. Moreover, pre-treatment of the mice with z-VAD-fmk, blocked the activated caspases and verified their participation in the TLR3-mediated innate immune signalling and cytokine production.
Our results provide, for the first time, evidence that caspases are central in regulating inflammatory cell infiltration and activation of innate immune responses in vivo following TLR3 stimulation.
Materials and methods

Mice
Female C57BL/6 mice weighing 18-21 g (Harlan Labs Ltd., Loughborough, UK) and aged 10-12 weeks were housed in a temperature-controlled environment under a 12 h light-dark cycle, with free access to food and water. All procedures were approved by the local ethics committee and performed under general anaesthesia under a Home Office license.
Poly (I:C) injury model
The C57BL/6 mouse SMGs were cannulated as previously performed in rats (Correia et al., 2010) and mice (Bombardieri et al., 2012) . Initially, a glass cannula (Supelco, 25715, PA-USA) was stretched over a flame and fitted into a polyethylene tube with 0.28 mm inner diameter. Polyinosinic-polycytidylic acid sodium salt (P1530-25MG, Sigma-Aldrich) was then diluted in 0.9% saline solution to a final concentration of 4 mg/ml. Towards consistent, visualised and flawless SMG injection, poly (I:C) was pre-mixed with Trypan blue (T8154-100ML-Sigma-Aldrich) prior to injection. Eighty micrograms of poly (I:C) in 20 μls were loaded into a 0.3 ml syringe (6134900, VWR International). For recovery experiments, mice were anaesthetised intraperitoneally (i.p) with 0.1 ml of combined 5 mg Ketamine/1 mg Xylazine. Under a stereomicroscope, the glass cannula was inserted into Wharton's duct and poly (I:C) was injected slowly and constantly into the left SMG (Fig. 1A) . The same volume of the vehicle (0.9% saline and Trypan blue) was delivered to the right SMG as a contralateral negative control.
Assessment of submandibular secretory function
Animals were anaesthetized with 150 μl of Pentobarbital Sodium (Euthatal, Merial) 1 mg/ml (i.p.), followed by endotracheal intubation. Each submandibular duct was exposed by dissection from the ventral surface through the mylohyoid muscle. Individual submandibular ducts were cut and saliva was collected using polyethylene tubes connected to insulin syringes (Fig. 1B) . Saliva collection proceeded for 5 min following onset of secretion after stimulation with pilocarpine (0.5 mg/kg i.p.). Following collection into pre-weighed Eppendorf tubes, the tubes were re-weighed, the volume of saliva was calculated as 1 mg = 1 μl saliva and results were expressed as μL saliva/min.
z-VAD-fmk and apoptosis inhibition model
Cell-permeable z-VAD-fmk (BD Pharmingen™, 550377) was dissolved in DMSO, aliquoted and stored at −80°C, and then diluted as needed in PBS for experiments. Mice were pre-treated intraperitoneally with z-VAD-fmk (10 mg/kg), 30 min prior to intraductal injection of poly (I:C) (Equils et al., 2009 ). In the current study, this group will be referred to as z-VAD-fmk + PIC. The contralateral submandibular gland was injected with the vehicle (0.9% saline and Trypan blue). Tissues were excised and saliva was collected 9 h following poly (I:C) intraductal injection.
TLR3/dsRNA complex inhibitor model
The TLR3/dsRNA complex inhibitor ((R)-2-(3-Chloro-6-fluorobenzo [b] thiophene-2 −carboxamido)-3-phenylpropanoic acid, Calbiochem Merck Millipore, 614310) was used to competitively disrupt poly (I:C) binding to TLR3 (Cheng et al., 2011) . The inhibitor was dissolved in DMSO and diluted in PBS. 1 mg/mouse of the inhibitor was intraperitoneally injected into mice (Takemura et al., 2014) . At the same time, 4 μg/μl poly (I:C) was combined to 50 ng TLR3/dsRNA and 20 μl of this solution was loaded in a 0.3 ml syringe. Mice were anaesthetised as previously mentioned and poly (I:C)-TLR3/dsRNA inhibitor were injected slowly and consistently into the SMG. In the current study, this group will be referred to as TLR3-I + PIC. The contralateral SMG was injected with the vehicle (0.9% saline, Trypan blue and 50 ng TLR3/ dsRNA complex inhibitor). Tissues were excised and saliva was collected 9 h following poly (I:C) intraductal injection.
Histopathologic examination
Harvested SMGs were fixed in 10% neutral buffer formalin, processed and embedded in paraffin for long term storage. Poly-(I:C) induced histomorphometric changes and immune cell infiltration were examined using conventional H&E stain and contrasted versus the saline injected control glands.
Immunohistochemical analysis
Three μm tissue sections were deparaffinized, rehydrated, and unmasked in a single step using Trilogy™ (Cell Marque, Rocklin, CA, 920P-06). To block endogenous peroxidase activity and non-specific background staining sections were incubated in 3% hydrogen peroxide solution for 20-30 min. To block all epitopes on the tissue samples and prevent nonspecific antibody binding, sections were incubated with 1% BSA in 1X TBS, pH7.6 for 5 min. Primary antibody (Table 1) was applied at the appropriate working dilution overnight at 4°C followed by secondary antibody (Table 1) which was incubated for 60 mins at room temperature. Colour was developed for 5 mins in DAB solution (Pierce™ 34002) and slides were counterstained in Mayer haematoxylin and DPX-mounted for light microscopy.
Western blotting
Tissues stored in RNAlater ® were retrieved, homogenized in cell lysis buffer (AA-LYS-10 ml-RayBiotech, Inc., Norcross, GA) plus protease inhibitor cocktail (1:10 dilution, Calbiochem, UK) using a FastPrep™ tissue homogenizer (MP Biomedicals Santa Ana, CA). Protein concentration was measured using the Qubit ® protein assay kit (Q33211, Invitrogen™, UK) and Qubit ® 3.0 Fluorometer (Q33216, Invitrogen™, UK) and a total of 15-20 μg/lane of the different lysates were separated by SDS-PAGE on a 4-12% Novex polyacrylamide gel (Invitrogen, UK). Electro-transfer of proteins was done for 1 h to 0.2 μm pore-size nitrocellulose membrane (1620112, Bio-Rad, UK) according to standard protocol (Invitrogen, UK, Paisley), followed by membrane blocking with 5% bovine serum albumin. Membranes were incubated at 4°C overnight with the appropriate antibody (Table 2) in blocking buffer then washed and incubated with the HRP conjugated anti-rabbit secondary antibody in blocking buffer at room temperature for 1 h. For signal development, an Enhanced Chemioluminescence substrate (ECL, GE Healthcare, UK) was prepared following the kit manufacturer's recommendations and applied over the membranes. Excess reagent was flicked and positive and negative protein expression was assessed and captured using ChemiDoc™ MP System (Bio-Rad, UK).
qRT-PCR analysis
For qRT-PCR analysis, SMGs stored in RNAlater ® (R0901-100 ml, Sigma-Aldrich) were homogenized using FastPrep™ tissue homogenizer (MP Biomedicals Santa Ana, CA) and RNeasy ® Micro Kit (74004, Qiagen) was used for total RNA extraction. RNA concentration as well as the A260/280 and A260/230 ratios were then measured with the NanoDrop ND-1000 Spectrophotometer (Thermo Fischer Scientific, Nottingham UK). iScript™ cDNA Synthesis kit (170-8890, Bio-Rad) was used to reverse transcribe 100 ng of extracted RNA. qPCR reactions (10 μl/well) were prepared by adding SsoAdvanced ™ Universal SYBR Green Supermix (172-5271, Bio-Rad), primers (PrimerDesign™, Ltd.) (Table 3 ) and cDNA template. Thermal cycling was performed using Corbett RotorGene 6000 System (Qiagen, UK). In all qRT-PCR experiments, relative gene quantification was assessed according to the "Delta Delta CT" (ΔΔCT) (Winer et al., 1999) , where ΔΔCT = [Ct GOI Exp -Ct HKG Exp-Ct GOI Cal -Ct HKG Cal]: Ct: cycle threshold, GOI: gene of interest, Exp: poly (I:C)-injected glands, HKG: housekeeping gene A. Shaalan et al. Molecular Immunology 94 (2018) 190-199 showing the highest stability within each experiment condition, Cal: control glands injected by the vehicle.
PCR array of mouse Toll-like receptor signaling pathway
To analyse the signalling pathway downstream of TLR3 ligation in SMGs from z-VAD-fmk treated and non-treated animals, the mouse RT 2 Profiler Toll-Like Receptor (TLR) signaling pathway array was used. RNA was extracted as previously mentioned and 800 ng was reverse transcribed using the RT 2 First Strand Kit (330401, Qiagen), according to the manufacturer's protocol. Twenty μl of the PCR reaction mix (Table 4 ) was added to individual wells of the RT 2 Profiler PCR array format R (PAMM-018ZR, Qiagen) and the thermal cycler was set according to http://www.SABiosciences.com/pcrarrayprotocolfiles.php. A threshold value above the background signal was chosen and the CT values for the run samples were extracted to an excel sheet and analysed using the web-based PCR Array Data Analysis Software available at www.SABiosciences.com/pcrarraydataanalysis.php. Altered expression was assessed by comparing poly (I:C) treated glands with their contralateral vehicle-injected control glands, from mice treated and non-treated with z-VAD-fmk. 
Digital image analysis of cleaved caspase-3 and MPO-immunopositive cells
In each tested group, fifteen random high magnification fields (five from three independent experiments) were captured and colour images of 640 × 480 pixel resolution were then analysed by semi-quantitative digitalized image analysis using ImageJ, NIH ® (Schneider et al., 2012) .
Briefly, images were transformed by threshold mode to locate the positive immunostained area, then converted to 8-bit images in grey scale. Subsequently, the area percentage of positive immunostaining was calculated by the area fraction command within measuring mode, which was expressed as the percentage of red pixels/SMG tissue section.
Statistical analysis
Results were shown as mean ± SEM (standard error of means). Statistical significance between individual comparisons was determined using Student t-test. For multiple comparisons, one-way ANOVA with Sidak's (selected pairs) pairwise tests were used. In addition, Dunnett test was performed for comparing treatment groups with the control group. The calculations were performed with the statistical software package GraphPad Prism (version 7). P values ≤ 0.05 were considered statistically significant.
Results
Poly (I:C) internalization and TLR3 upregulation
To visualize poly (I:C) internalization, a dsRNA monoclonal antibody was used to track its fate post retrograde injection into the SMG duct. The vehicle-injected SMGs did not show any dsRNA-positive signal. Conversely, the ducts and acini of the poly (I:C)-injected SMGs showed retention of poly (I:C) up to 24 h following its injection (Fig. 1C) . Next, qRT-PCR was performed and revealed that poly (I:C) induced the transcriptional upregulation of TLR3 in the SMGs. Immunohistochemical staining was performed in order to identify cell phenotypes expressing the activated receptor. Basally, TLR3 showed intense membranous and cytoplasmic immunostaining in the intercalated ducts. Following poly (I:C) introduction, TLR3 showed immunopositivity in the basolateral membranes of acinar and duct cells with increased numbers of intensely stained intercalated ducts ( Fig. 2A) .
z-VAD-fmk blocked casp-8/csp-3 activated signals induced by TLR3 stimulation
Mice were pre-treated with the TLR3/dsRNA complex inhibitor, which competitively inhibits dsRNA binding to TLR3 and immunohistochemistry was performed to explore the role played by TLR3 in caspase activation. A single poly (I:C) dose induced an extremely significant increase in the percentage of glandular epithelial cells expressing the apoptotic marker: cleaved caspase-3, compared to the Fig. 3 . A: Western blot representation of caspase-8 and caspase-3 in the SMGs, 9 h post poly (I:C) infection. Poly (I:C) induced caspase activation in a TLR-3-dependent manner. The protein products of caspase-8 and caspase-3 extracted from three independent vehicle (V-C), poly (I:C) (P-PIC) injected, TLR3-blocked (TLR3-I+PIC) and caspase-inhibited (z-VAD-fmk +PIC) SMGs, were measured by Western blot analysis. Bars represent the fold change in protein levels of activated subunits of caspase-8 and caspase-3, on the basis of β-actin and indicate mean values ± SEM (n = 3 in each group). ns: non-significant, ***P < 0.001, ****p < 0.0001 significant differences between the V-C and tested groups. B: Immunohistochemical expression of cleaved caspase-3 in SMGs from z-VAD-fmk-treated and non-treated mice, 9 h P-PIC introduction.
vehicle injected control and the TLR3-inhibited glands (p < 0.0001) (Fig. 2B) . In another set of experiments, mice were pre-treated with 10 mg/kg z-VAD-fmk intraperitoneally, 30 min prior to intraductal minfusion of poly (I:C). Subsequently, SMGs were harvested and analysed by western blot to confirm blockade of the TLR-3-triggered apoptotic signal. Results obtained from these experiments confirmed that z-VAD-fmk pre-treatment interfered with expression levels of the TLR3-activated subunits of caspase-8/-3 in the poly (I:C)-injected glands (Fig. 3A) . In addition, immunohistochemistry, showed downregulated expression of cleaved caspase 3 in the SMGs of the z-VAD-fmk treated animals, compared to those which received poly (I:C) only (Fig. 3B) .
z-VAD-fmk inhibited infiltration of TLR-3-recruited, MPO-positive, acute inflammatory cells
H&E sections from SMGs of the control, poly (I:C)-injected, TLR-3 blocked and z-VAD-treated mice were microscopically examined and revealed that the poly (I:C)-infected glands from both the z-VAD treated and TLR-3-inhibited mice were inflammation-and oedema-free; two hallmark features of the glands injected with poly (I:C) only (Fig. 4) . Next, the anti-inflammatory effect of z-VAD in the poly (I:C) infected glands was verified by immunolabelling tissues with the acute inflammatory marker: MPO (expressed in lysosomes of monocytes and azurophilic granules of neutrophils) (Klebanoff, 2005) ) and comparing the results to those in the TLR3/dsRNA blockade model. Immunohistochemistry similarly confirmed the H&E results, whereby the SMGs from the poly (I:C) treated mice displayed many MPO positive A. Shaalan et al. Molecular Immunology 94 (2018) 190-199 immune cells, which were absent from the z-VAD-or TLR3-inhibitortreated mice (Fig. 4) .
Effect of z-VAD-fmk on pilocarpine stimulated saliva secretion
To rule out induction of necroptotic cell death, which is coupled to caspase inhibition (Philip et al., 2016) , the viability of the secretory parenchymal cells was assessed by exploring the functional response of the SMGs to pilocarpine stimulation. Blockade of active caspases using the z-VAD-fmk inhibitor preserved SMG secretory capacity, which had clearly deteriorated 9 h post intraductal infusion of poly (I:C). Similar functional protection was conferred by competitively blocking TLR3 (Fig. 5) .
Pan caspase inhibition interfered with transcriptional activation of TLR-related and interferon (IFN) stimulated genes
The mouse RT2 Profiler™ TLR PCR array of 84 TLR-related innate immune adaptor and effector genes was used to broadly analyse SMG response to blockade of the caspase system by z-VAD-fmk. Intriguingly, pre-treating mice with z-VAD-fmk prior to poly (I:C) injection, reduced the expression level of all TLR-related genes, compared to their extensive transcriptional upregulation in the SMGs which received the innate immune stimulant only (Fig. 6A and Tables 5a and 5b). In addition, specific primers for interferon-responsive genes were used to confirm this novel, negative feedback mechanism executed by caspase inhibition with z-VAD-fmk (Fig. 6B ). In red, up-regulated genes; in green, down regulated genes; and in black, genes not altered. Blocking the apoptotic signal in the SMGs by pre-treating mice with z-VAD-fmk, reduced the expression level of all TLR-related genes, compared to the extensive transcriptional upregulation seen in the SMGs which received poly (I:C) only. One representative experiment presented from three biological repeats. B: mRNA relative expression of the IFN-response genes: Mx1 and ISG15. Note the extremely significant (p < 0.0001) decrease in the expression of the tested genes in the glands from z-VAD-fmk-treated animals. Data represents means ± SEM (n = 3). ns: non-significant p > 0.05, *P ≤ 0.05, ****p ≤ 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Caspases are central in regulating the expression of TLR-3-induced proinflammatory cytokines
To further define the immune regulatory functions of caspases, we investigated their potential contribution to cytokine production in response to TLR-3 stimulation. SMGs from the TLR3-inhibited and z-VADfmk-treated mice exhibited a dramatic decline in the transcriptional activation of the pleotropic cytokines, IL-6 and IL-1β compared to the vehicle injected control glands (Fig. 7A & B, left) . In addition, protein levels of IL-6, activated IL-1β isoform (Fig. 7A & B, right) and inducible nitric oxide synthase (iNOS) (Fig. 7C) were greatly diminished in parenchymal cells, following ductal injection with poly (I:C).
Discussion
The current study provides in vivo evidence that caspases regulate the TLR3-activated innate immune response. This conclusion is consistent with the important role played by caspases in coordinating and integrating signals that result not only in apoptosis but also inflammation and immune regulation (Creagh, 2014) . Previous studies demonstrated that multiple, systemic injections of poly (I:C) into Sjӧgren's syndrome-prone, NZB/WF1 mice, resulted in loss of glandular function (Deshmukh et al., 2009; Nandula et al., 2013) . The TLR3-stimulant in the current model was locally injected into the SMGs to avoid systemic delivery, which is more likely to dilute the poly (I:C) and minimize the chance of its efficient exposure to salivary parenchymal cells. Moreover, the model presented herein, is unique in demonstrating the direct influence of innate immune activation on the SMG tissues and functional responses, ruling out possible extraneous impacts arising either from systemic delivery or autoimmune susceptibility of mice. The cannulation technique established, enabled the development of a reliable and reproducible mouse model, whereby intraductal conveyance of poly (I:C) pre-mixed with Trypan blue allowed consistently successful infusion and delivery of the same amount of inflammagen into the SMGs (even when other drugs such as TLR3/dsRNA inhibitor and z-VAD-fmk, were used). Parenchymal exposure to poly (I:C) and its efficient internalization into the SMG ductal and acinar cells were verified using the J2 monoclonal antibody which specifically recognizes dsRNA of more than 40 base pairs in length (Schonborn et al., 1991) . The J2 antibody positively stained acinar and ductal cells which internalized the poly (I:C) and revealed that parenchymal cells retain the inflammagen up to 24 h post inoculation.
The involvement of TLR3 in dsRNA-triggered apoptosis has previously been demonstrated by RNA interference (Salaun et al., 2006; Jego et al., 2006) . Upon ligand recognition, TLR3 recruits the adaptor protein TRIF, which then interacts with the receptor interacting protein 1 (RIP1), a serine/threonine kinase that not only enhances survival through NF-κB and MAPK activation, but also promotes apoptosis by recruiting FADD and by activating caspase-8 (Han et al., 2004) . Activated caspase-8 cleaves and activates caspase-3, which then executes the apoptotic program (Aliprantis et al., 2000) . Intraductal infusion of the poly (I:C) into the SMGs prompted transcriptional upregulation of TLR3, which triggered the expression of activated forms of caspase-8 and caspase-3. Cleaved caspase-3-positive duct and acinar cells were observed as early as 9 h after poly (I:C) administration and were significantly decreased in the mice treated with the pan caspase inhibitor z-VAD-fmk. Surprisingly, systemic injection of z-VAD-fmk before challenging the SMG innate immune response, interfered with acute Table 5b Fold change in the expression of mRNA of TLR-related genes 6 h following z-VAD-fmk pre-treatment and poly (I:C) injection. mRNA expression was assessed using an RT 2 Profiler TollLike Receptor (TLR) signaling pathway array. A. Shaalan et al. Molecular Immunology 94 (2018) 190-199 inflammatory cell infiltration and protected the SMG secretory machinery from the poly (I:C)-induced loss of function. z-VAD-fmk has shown therapeutic efficacy in many diseases including neurogenic pulmonary edema (Suzuki et al., 2009) , muscle ischemia-reperfusion injury (Iwata et al., 2002) and allergic lung inflammation (Iwata et al., 2003) . Caspases are closely inter-connected with cytokines and cytokine receptors, in that some caspases are essential for cytokine maturation (i.e. activation) and secretion. Caspase-1 cleaves pro-IL-1β and pro-IL-18 to the mature cytokine forms (Fantuzzi and Dinarello, 1999) . In addition, caspase-3 is involved in the processing of pro-IL-16 to the mature cytokine (Zhang et al., 1998) . It has been previously shown that z-VAD-fmk inhibition of caspase-3 led to the down-regulation of JNK/ SAPK and NF-kB, which were required for LPS-induced iNOS expression and NO production (Chakravortty et al., 2001 ). Moreover, caspase-8 has been reported to directly cleave pro IL-1β into its mature, active form following TLR3/TLR4 stimulation (Maelfait et al., 2008) , in addition to its direct activation of the inflammatory caspase-1, in an inflammasome-independent manner (Philip et al., 2014) . IL-1β can recruit a cascade of events downstream of the IL-1R complex, resulting in the activation of important signalling proteins, such as mitogen-activated kinases (JNK, p38, ERK1/2), as well as transcription factors, including NFκB (p65 and p50 subunits) and c-Jun (a subunit of AP-1), which control expression of a number of inflammatory and catabolic genes (Risbud and Shapiro, 2014) . Whether TLR3 engages caspases for maximal cytokine production is not known, but the broad anti-inflammatory effect provided by z-VAD-fmk in the current injury model may have been down to its ability to inhibit caspases that cleave pro-IL-1β into its active form.
In addition to their apoptotic contribution, a new paradigm for caspases in non-apoptotic roles has become clear. In the current study, the pan caspase inhibitor, z-VAD-fmk negatively regulated the expression of an array of TLR-related and IFN-stimulated genes. This finding may be due to the pleiotropic role of caspase-8 in the control of gene expression downstream of TLR stimulation (Moen et al., 2016) , via: (i) induction of mRNA transcription and promotion of mRNA stability (Philip et al., 2016) , (ii) localization to nuclei, raising the possibility that nuclear caspase-8 might play a role in gene expression (BesnaultMascard et al., 2005) and (iii) regulating the activation of the transcription factor NF-κB (Moen et al., 2016; Lemmers et al., 2007; Weng et al., 2014; Su et al., 2005) , which induces the expression of target genes, including cytokines, chemokines, and adhesion molecules (Traenckner et al., 1995) .
IFNs contribute to immune protection through the induction of cellular antimicrobial programmes and through enhancing immune responses for the efficient termination of infection (McNab et al., 2015) . However, type-I-IFNs can also be harmful, either by inducing immunosuppressive effects that impede viral control (Biron, 2001 ) or by . Western blot analysis of cleaved IL-1β in SMGs from control (V-C) and poly (I:C) (P-PIC) injected groups, with TLR3/dsRNA complex inhibitor or the caspase inhibitor z-VAD-fmk. Poly (I:C) induced the expression of the mature IL-1β isoform in the SMGs, which was efficiently abrogated by TLR3 blockade or pan caspase inhibition. The data are representative of results from three independent experiments. C: Immunohistochemistry and western blot revealed that pan caspase inhibition remarkably diminished the TLR-3-induced acinar iNOS overproduction (arrows). Bars represent the fold change of iNOS protein levels on the basis of β-actin and indicate mean values ± SEM (n = 3 in each group). Western blot data are representative of results from three independent experiments. ns: nonsignificant p > 0.05, *P < 0.05, significant differences between the V-C and tested groups. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) triggering inflammation and tissue damage that exacerbate disease (Davidson et al., 2014) . The results from arrays in the present study show very remarkable downregulation of the poly (I:C) induced Ifnb1 from 445 folds to 5 folds, when mice received the pan caspase inhibitor prior to poly (I:C). To confirm this novel and therapeutically significant finding, qRT-PCR was carried out to further analyse the mRNA expression levels of IFN-response genes in poly (I:C) treated SMGs from the z-VAD-fmk treated and non-treated mice. Results from these experiments confirmed the array finding and revealed for the first time that caspase inhibition can potentially control unruly type I IFN-regulated genes. However, the mechanism(s) by which caspases directly or indirectly regulate the IRF-pathway in SMGs has not previously been addressed. Thus, further studies are needed to determine the importance of caspases for IRF signalling in response to TLR agonists in vivo.
In conclusion, the current study is the first to demonstrate that the broad-spectrum caspase inhibitor z-VAD-fmk can regulate TLR3-induced gene expression and cytokine production in vivo, during the early stages of innate immune activation and inflammation.
